CK-MB Test Kit (Dry Fluorescence Immunoassay)

CK-MB Test Kit (Dry Fluorescence Immunoassay) is intended for in-vitro quantitative measurement of CK-MB in human serum and plasma. This test is used as an aid in the clinical diagnosis, prognosis and evaluation of myocardial injury such as Acute Myocardial Infarction (AMI), Unstable Angina, Acute Myocarditis and Acute Coronary Syndrome (ACS).

Myo Test Kit (Dry Fluorescence Immunoassay)

Myo Test Kit (Dry Fluorescence Immunoassay) is intended for in-vitro quantitative measurement of Myo (Myoglobin) in human serum and plasma. This test is used as an aid in the clinical diagnosis, prognosis and evaluation of myocardial injury such as Acute Myocardial Infarction (AMI), Unstable Angina, Acute Myocarditis and Acute Coronary Syndrome (ACS).

cTnI/CK-MB/Myo Test Kit (Dry Fluorescence Immunoassay)

cTnI /CK-MB/Myo Test Kit (Dry Fluorescence Immunoassay) is intended for in-vitro quantitative measurement of cTnI /CK-MB/Myo (Cardiac Troponin I/ Creatine Kinase Isozyme/Myoglobin ) in human serum . cTnI is used as an aid in the diagnosis of myocardial injury such as Acute Myocardial Infarction (AMI),Unstable Angina, Acute Myocarditis and Acute Coronary Syndrome (ACS). CK-MB is an important indicator for the diagnosis of acute myocardial infarction (AMI), which is secreted into the blood in large quantities during the attack.CK-MB began to rise 3-6h when AMI symptoms occur, and reached the peak value after 12-24h. If there were no complications, the level of CK-MB in the blood would be restored to the normal level after 3d; if there were complications, the level of CK-MB in the blood would remain high and not decrease. If AMI occurs again, the CK-MB that has declined will rise again. CK-MB measurement can also be used as a non-invasive evaluation index for myocardial reperfusion after thrombolytic therapy. Myo can be used as the most sensitive index in the early diagnosis of acute myocardial infarction (AMI).

cTnI Test Kit (Dry Fluorescence Immunoassay)

cTnI Test Kit (Dry Fluorescence Immunoassay) is intended for in-vitro quantitative measurement of cTnI (Cardiac Troponin I) in serum and plasma. This test is used as an aid in the diagnosis of myocardial injury such as Acute Myocardial Infarction (AMI), Unstable Angina, Acute Myocarditis and Acute Coronary Syndrome (ACS).

NT-proBNP Test Kit (Dry Fluorescence Immunoassay)

NT-proBNP Test Kit (Dry Fluorescence Immunoassay) is intended for in-vitro quantitative measurement of NTproBNP (N-terminal Brain Natriuretic Peptide Precursor) in human serum and plasma. NT-proBNP can be used to evaluate heart contractile, diastolic dysfunction, and ventricular segment wall motion coordination. NT-proBNP is used to indicate heart failure patient at the early stage, determine HF risk levels, monitor medical efficiency of HF drug, evaluate prognosis of HF patient and to distinguish dyspnea that caused by HF from other diseases. Furthermore, NT-proBNP is a risk assessment indicator for Acute Coronary Syndrome (ACS).

D-Dimer Test Kit (Dry Fluorescence Immunoassay)

D-Dimer Test Kit (Dry Fluorescence Immunoassay) is intended for in-vitro quantitative measurement of D-Dimer in human plasma. This test is used as an aid in the assessment and evaluation of patients suspected of deep vein thrombosis (DVT) and pulmonary embolism (PE), diagnosis of disseminated intravascular coagulation (DIC), effective evaluation and monitoring the effect of thrombolytic therapy, diagnosis and assessment of myocardial infarction and cerebral infarction.

H-FABP Test Kit (Dry Fluorescence Immunoassay)

H-FABP Test Kit (Dry Fluorescence Immunoassay) is intended for in-vitro quantitative measurement of H-FABP (heart-type fatty acid binding protein) in human serum and plasma. H-FABP is a new kind of cytoplasmic protein abundant in the heart.H-FABP is highly cardiac specific (that is, expressed mainly in heart tissue), but is also expressed in low concentrations outside the heart.After myocardial ischemic injury occurs, H-FABP can be detected in the blood as early as 1-3 hours after chest pain attack, peak at 6-8 hours, and return to normal within 24-30 hours.Therefore, H-FABP is regarded as a useful biomarker for early diagnosis of myocardial injury.Immunofluorescence assay is commonly used in clinical laboratories.

FDP Test Kit (Dry Fluorescence Immunoassay)

FDP Test Kit (Dry Fluorescence Immunoassay) is intended for in-vitro quantitative measurement of FDP in human plasma and whole blood.

ST2 Test Kit (Dry Fluorescence Immunoassay)

The ST2 test kit is based on the principle of immunofluorescence double antibody sandwich method used to quantitatively detect the content of ST2.

BNP Test Kit (Dry Fluorescence Immunoassay)

BNP Test Kit (Dry Fluorescence Immunoassay) is intended for in-vitro quantitative measurement of Brain Natriuretic Peptide (BNP) in plasma. Upon stimulamyocardial hypoxia, ischemia, etc.), a type B natriuretic peptide tion of cardiomyocytes mechanical ventricular traction, precursor (pre-proBNP) containing 134 amino acids is produced, followed by the formation of a BNP precursor (proBNP) containing 108 amino acids, which is cleaved by activating enzymes into NT-proBNP containing 76 amino acids and BNP of 32 amino acids. BNP is mainly used as an aid in the diagnosis of heart failure.